Ticker: CO, Company: China Cord Blood Corp, Type: 20-F, Date: 2011-09-28
Original SEC Filing: Click here

---

Webplus: CO/20110928/20-F/1/000.htm SEC Original: v233979_20f.htm
FORM 20-F OR x For the fiscal year ended March 31, 2011. OR ORte of event requiring this shellmpany report: For the transition period from ________ to ________ Chinard Bloodrporationyman Islands (Jurisdiction oforporation or organization) 48th Floor, Bank of China Tower 1 Garden Road Central, Hong KongR.

---

---

Webplus: CO/20110928/20-F/2_EX-4.5/000.htm SEC Original: v233979_ex4-5.htm
Summary of Loanreementreement #[ ] Party A (Borrower): Beijing Jiachenhong Biological Technologies, Party B (Lender): Huaxia Bank, Beijing Xiushui Branch Article 1 Type of Loan WorkingpitalLoan Article 2 Amount and Currency of Loan 2.1 The currency of the loan stipulated in thereement is Renminbi (RMB).

---

---

Webplus: CO/20110928/20-F/3_EX-4.10/000.htm SEC Original: v233979_ex4-10.htm
CordLife (Hong Kong) and Chinard Bloodrporation Marketingllaborationreement This Marketingllaborationreement (Agreement) isted theteecified on the execution page of thisreement.rdLife (Hong Kong) (CordLife HK), 31006823 AND Chinard Bloodrporation (“CCBC”), WHEREAS A.rdLife HK offers services ofrd blood stem cellllection, processing, testing and storage services to citizens of China giving birth in Hong Kong and their new born baby

---

---

Webplus: CO/20110928/20-F/4_EX-8.1/000.htm SEC Original: v233979_ex8-1.htm
List of Subsidiaries Name Jurisdiction Chinard Blood Servicesrporationyman Islands China Stem Cellss Limitedyman Islands Beijing Jiachenhong Biological Technologies Limited Peoples Republic of China China Stem Cells (South)mpany Limited British Virgin Islands Guangzhou Municipality Tianhe Nuoya Bio-engineering Peoples Republic of China China Stem Cells (East)mpany Limited

---

---

Webplus: CO/20110928/20-F/5_EX-12.1/000.htm SEC Original: v233979_ex12-1.htm
Certification I, Ting Zheng, certify that: 1. I have reviewed this annual report on Form 20-F of Chinard Bloodrporation; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which

---

---

Webplus: CO/20110928/20-F/6_EX-12.2/000.htm SEC Original: v233979_ex12-2.htm
Certification I,bert Chen, certify that: 1. I have reviewed this annual report on Form 20-F of Chinard Bloodrporation; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such

---

---

Webplus: CO/20110928/20-F/7_EX-13.1/000.htm SEC Original: v233979_ex13-1.htm
Certification CHINARD BLOODRPORATION September 28, 2011 Ting Zheng Chief Executive Officer September 28, 2011bert Chen Chief Financial Officer (Principal Financial and Accounting Officer) v233979_ex13-1.htm 7 EX-13.1

---

---

Webplus: CO/20110928/20-F/8_EX-15.1/000.htm SEC Original: v233979_ex15-1.htm
Consent of Independent Registered Public Accounting Firm The Board of Directors Chinard Bloodrporation: Our reportted September 27, 2011 on thensolidated financial statementsntains an explanatory paragraph that states thempanympleted a share exchange with Chinard Blood Servicesrporation (CCBS) on June 30, 2009 and the share exchange has been accounted for financial reporting purposes the issuance of securities

---

Company Information:

Ticker: CO, Company: China Cord Blood Corp, Type: 20-F, Date: 2011-09-28CIK: 0001467808, Location: K3, SIC: 6770, SIC Desc: BLANK CHECKS
Business Phone & Address:
48 FL., BANK OF CHINA TOWER, 1 GARDEN ROAD
CENTRAL HONG KONG, K3 000000